Evidence map›Paper›PMID 38779720›Full record

ArticleHaematologica2024

Clinical phenotype of adult-onset systemic histiocytosis harboring

Matthias Papo, Jérôme Razanamahéry, Malik Da Silva, Zofia Hélias-Rodzewicz, Vsevolod Potapenko, Suzanna Bota, Vanessa Leguy-Seguin, Stéphane Dominique, Raphaël Lhote, Quentin Moyon and 10 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Matthias PapoInternal Medicine Department 2, French National Referral Center for Rare Systemic Diseases and Histiocytoses, Sorbonne University, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris. matthias.papo@aphp.fr.
Jérôme RazanamahéryDepartment of Internal Medicine and Clinical Immunology, Dijon University Hospital, Dijon.
Malik Da SilvaParis-Saclay University, Versailles SQY University, Assistance Publique-Hôpitaux de Paris, Ambroise-Paré Hospital, Smart Imaging, Service de Pathologie, Boulogne.
Zofia Hélias-RodzewiczParis-Saclay University, Versailles SQY University, Assistance Publique-Hôpitaux de Paris, Ambroise-Paré Hospital, Smart Imaging, Service de Pathologie, Boulogne.
Vsevolod PotapenkoMunicipal educational hospital №31, Saint-Petersburg, Russia.
Suzanna BotaDepartment of Pneumology, CHU ROUEN, F-76000 ROUEN.
Vanessa Leguy-SeguinDepartment of Internal Medicine and Clinical Immunology, Dijon University Hospital, Dijon.
Stéphane DominiqueDepartment of Pneumology, CHU ROUEN, F-76000 ROUEN.
Raphaël LhoteInternal Medicine Department 2, French National Referral Center for Rare Systemic Diseases and Histiocytoses, Sorbonne University, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris.
Quentin MoyonInternal Medicine Department 2, French National Referral Center for Rare Systemic Diseases and Histiocytoses, Sorbonne University, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris.
Dov TaïebInternal Medicine Department 2, French National Referral Center for Rare Systemic Diseases and Histiocytoses, Sorbonne University, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris.
Tom AbrassartInternal Medicine Department 2, French National Referral Center for Rare Systemic Diseases and Histiocytoses, Sorbonne University, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris.
Marion CampanaPneumology Department, Source hospital, Orléans.
Visal KeoInternal medicine departement, Bayonne hospital, Bayonne France.
Etienne RivièreDepartment of internal Medicine and Infectious Diseases Department, Haut Leveque Hospital, University Hospital Centre of Bordeaux, F33604 Pessac.
Olivier LucidarmeAPHP Sorbonne Universités Pitié-Salpêtrière Hospital and UMR 7371, UMR_S 1146, Laboratoire d'Imagerie Biomédicale, F-75013, Paris.
Fleur Cohen-AubartInternal Medicine Department 2, French National Referral Center for Rare Systemic Diseases and Histiocytoses, Sorbonne University, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris.
Zahir AmouraInternal Medicine Department 2, French National Referral Center for Rare Systemic Diseases and Histiocytoses, Sorbonne University, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris.
Julien HarocheInternal Medicine Department 2, French National Referral Center for Rare Systemic Diseases and Histiocytoses, Sorbonne University, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris.
Jean-François EmileParis-Saclay University, Versailles SQY University, Assistance Publique-Hôpitaux de Paris, Ambroise-Paré Hospital, Smart Imaging, Service de Pathologie, Boulogne.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

PhenotypeProto-Oncogene Proteins B-rafAdultAgedAge of OnsetFemaleHistiocytosisHumansMaleMiddle AgedSequence DeletionBRAF protein, humanProto-Oncogene Proteins B-raf

Identifiers

PMID38779720
PMCPMC11367196

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.